NM_017882.3:c.64G>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017882.3(CLN6):​c.64G>T​(p.Ala22Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000745 in 1,466,394 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A22T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0040 ( 1 hom., cov: 34)
Exomes 𝑓: 0.00037 ( 2 hom. )

Consequence

CLN6
NM_017882.3 missense

Scores

1
2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.119

Publications

2 publications found
Variant links:
Genes affected
CLN6 (HGNC:2077): (CLN6 transmembrane ER protein) This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq, Oct 2008]
CLN6 Gene-Disease associations (from GenCC):
  • ceroid lipofuscinosis, neuronal, 6A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P
  • ceroid lipofuscinosis, neuronal, 6B (Kufs type)
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Genomics England PanelApp
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043364763).
BP6
Variant 15-68229521-C-A is Benign according to our data. Variant chr15-68229521-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 193390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00396 (602/152094) while in subpopulation AFR AF = 0.0132 (550/41548). AF 95% confidence interval is 0.0123. There are 1 homozygotes in GnomAd4. There are 276 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017882.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN6
NM_017882.3
MANE Select
c.64G>Tp.Ala22Ser
missense
Exon 1 of 7NP_060352.1Q9NWW5-1
CLN6
NM_001411068.1
c.180-10871G>T
intron
N/ANP_001397997.1Q9NWW5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN6
ENST00000249806.11
TSL:1 MANE Select
c.64G>Tp.Ala22Ser
missense
Exon 1 of 7ENSP00000249806.5Q9NWW5-1
CLN6
ENST00000637667.1
TSL:1
c.64G>Tp.Ala22Ser
missense
Exon 1 of 6ENSP00000489843.1A0A1B0GTU6
CLN6
ENST00000566347.5
TSL:1
c.64G>Tp.Ala22Ser
missense
Exon 1 of 6ENSP00000457783.1H3BUT1

Frequencies

GnomAD3 genomes
AF:
0.00397
AC:
603
AN:
151988
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0133
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000448
AC:
36
AN:
80346
AF XY:
0.000413
show subpopulations
Gnomad AFR exome
AF:
0.0148
Gnomad AMR exome
AF:
0.000872
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000172
Gnomad OTH exome
AF:
0.00127
GnomAD4 exome
AF:
0.000373
AC:
490
AN:
1314300
Hom.:
2
Cov.:
31
AF XY:
0.000329
AC XY:
213
AN XY:
647994
show subpopulations
African (AFR)
AF:
0.0110
AC:
290
AN:
26432
American (AMR)
AF:
0.00115
AC:
31
AN:
26910
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22840
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28178
South Asian (SAS)
AF:
0.0000137
AC:
1
AN:
73050
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32614
Middle Eastern (MID)
AF:
0.000768
AC:
3
AN:
3904
European-Non Finnish (NFE)
AF:
0.0000965
AC:
101
AN:
1046156
Other (OTH)
AF:
0.00118
AC:
64
AN:
54216
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
25
50
74
99
124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00396
AC:
602
AN:
152094
Hom.:
1
Cov.:
34
AF XY:
0.00371
AC XY:
276
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.0132
AC:
550
AN:
41548
American (AMR)
AF:
0.00236
AC:
36
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10524
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
67950
Other (OTH)
AF:
0.00284
AC:
6
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
35
69
104
138
173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000140
Hom.:
0
Bravo
AF:
0.00431
ExAC
AF:
0.000148
AC:
3

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Neuronal ceroid lipofuscinosis (2)
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
14
DANN
Benign
0.96
DEOGEN2
Benign
0.11
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.79
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-0.41
T
MutationAssessor
Benign
1.4
L
PhyloP100
0.12
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-3.0
D
REVEL
Benign
0.12
Sift
Benign
0.27
T
Sift4G
Pathogenic
0.0
D
Polyphen
0.14
B
Vest4
0.15
MVP
0.61
MPC
0.079
ClinPred
0.014
T
GERP RS
1.3
PromoterAI
-0.12
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.084
gMVP
0.26
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs527373013; hg19: chr15-68521859; COSMIC: COSV106084475; COSMIC: COSV106084475; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.